NASDAQ:CYBE - CyberOptics Stock Price, Forecast & News

CyberOptics' stock was trading at $16.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CYBE stock has decreased by 11.1% and is now trading at $14.98. View which stocks have been mosted impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CyberOptics in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CyberOptics.

CyberOptics is scheduled to release its next quarterly earnings announcement on Wednesday, April 22nd 2020. View our earnings forecast for CyberOptics.

CyberOptics Co. (NASDAQ:CYBE) announced its quarterly earnings data on Wednesday, February, 19th. The scientific and technical instruments company reported $0.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.01 by $0.01. The scientific and technical instruments company had revenue of $16.85 million for the quarter. CyberOptics had a return on equity of 1.34% and a net margin of 1.31%. View CyberOptics' earnings history.

CyberOptics updated its first quarter 2020 After-Hours earnings guidance on Wednesday, February, 19th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $15-16.5 million, compared to the consensus revenue estimate of $14.04 million.

2 equities research analysts have issued 12 month price targets for CyberOptics' stock. Their forecasts range from $27.00 to $29.00. On average, they expect CyberOptics' share price to reach $28.00 in the next twelve months. This suggests a possible upside of 86.9% from the stock's current price. View analysts' price targets for CyberOptics.

Media coverage about CYBE stock has been trending extremely negative this week, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CyberOptics earned a media sentiment score of -5.0 on InfoTrie's scale. They also assigned news stories about the scientific and technical instruments company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutCyberOptics.

CyberOptics saw a drop in short interest in the month of March. As of March 13th, there was short interest totaling 159,300 shares, a drop of 9.9% from the February 27th total of 176,800 shares. Based on an average daily trading volume, of 37,600 shares, the days-to-cover ratio is presently 4.2 days. Currently, 2.3% of the shares of the stock are short sold. View CyberOptics' Current Options Chain.

Some companies that are related to CyberOptics include KLA (KLAC), II-VI (IIVI), Nova Measuring Instruments (NVMI), Topcon (TOPCF), Camtek (CAMT), Perceptron (PRCP), Optex Systems Hldg InCorp (OPXS) and ProPhotonix (STKR).

Based on aggregate information from My MarketBeat watchlists, some companies that other CyberOptics investors own include Alibaba Group (BABA), Intel (INTC), Napco Security Technologies (NSSC), Primo Water (PRMW), Verizon Communications (VZ), Comcast (CMCSA), Cisco Systems (CSCO), Tesla (TSLA), Walt Disney (DIS) and Ford Motor (F).

CyberOptics trades on the NASDAQ under the ticker symbol "CYBE."

CyberOptics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Royce & Associates LP (4.34%), Epiq Partners LLC (1.45%), Cadence Capital Management LLC (1.33%), Penbrook Management LLC (1.31%), Geode Capital Management LLC (0.71%) and Marshall Wace LLP (0.62%). View institutional ownership trends for CyberOptics.

CYBE stock was sold by a variety of institutional investors in the last quarter, including Alambic Investment Management L.P., Cadence Capital Management LLC, Crescent Grove Advisors LLC, Penbrook Management LLC, Bank of New York Mellon Corp, Marshall Wace North America L.P., Wedge Capital Management L L P NC, and Ladenburg Thalmann Financial Services Inc.. View insider buying and selling activity for CyberOptics.

CYBE stock was purchased by a variety of institutional investors in the last quarter, including Epiq Partners LLC, THB Asset Management, Renaissance Technologies LLC, Acadian Asset Management LLC, Credit Suisse AG, Oxford Asset Management LLP, Royce & Associates LP, and Marshall Wace LLP. View insider buying and selling activity for CyberOptics.

Shares of CYBE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CYBE stock can currently be purchased for approximately $14.98.

CyberOptics has a market capitalization of $107.26 million and generates $59.26 million in revenue each year. The scientific and technical instruments company earns $770,000.00 in net income (profit) each year or $0.11 on an earnings per share basis. CyberOptics employs 178 workers across the globe. View additional information about CyberOptics.

The official website for CyberOptics is http://www.cyberoptics.com/.

CyberOptics' mailing address is 5900 GOLDEN HILLS DRIVE, GOLDEN VALLEY MN, 55416. The scientific and technical instruments company can be reached via phone at 763-542-5000 or via email at [email protected]